HuGE Literature Finder
Records
1
-
2
Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Patients. Frontiers in pharmacology 2020 11 664. Liao Dehua, Liu Zhigang, Zhang Yongchang, Liu Ni, Yao Dunwu, Cao Lizhi, Chen Yun, Fu Yilan, Yang Nong, Xiang Daxio |
Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis. Arthritis research & therapy 2012 14 (4): R163. Wiese Michael D, Schnabl Matthew, O'Doherty Catherine, Spargo Llewellyn D, Sorich Michael J, Cleland Leslie G, Proudman Susanna |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: